Crossref Citations
This article has been cited by the following publications. This list is generated based on data provided by
Crossref.
Taylor, David M.
Sparshatt, Anna
O’Hagan, Maria
and
Dzahini, Olubanke
2016.
Paliperidone palmitate: factors predicting continuation with treatment at 2 years.
European Neuropsychopharmacology,
Vol. 26,
Issue. 12,
p.
2011.
Taylor, David M
Sparshatt, Anna
Amin, Fahima
Osborne, Ian
Dzahini, Olubanke
Hughes, Gwenllian
and
Fischetti, Catrin
2017.
Aripiprazole long-acting injection – a mirror image study of its effects on hospitalisation at one year.
Journal of Psychopharmacology,
Vol. 31,
Issue. 12,
p.
1564.
Hargarter, Ludger
Lahaye, Marjolein
Cherubin, Pierre
Lambert, Martin
Swarz, Marnina
Joldygulov, Gali
Vischia, Flavio
Chomskaya, Veronica
Bozikas, Vasilis P.
Tsapakis, Eva-Maria
and
Schreiner, Andreas
2018.
Treatment response and tolerability with once-monthly paliperidone palmitate initiated shortly after hospital admission in patients with schizophrenia.
The World Journal of Biological Psychiatry,
Vol. 19,
Issue. sup3,
p.
S147.
Desai, Mitesh
Wooller, Annette
Lignugaris, Arunas
and
Gopal, Srihari
2018.
Letter to the Editor: Is paliperidone palmitate more effective than other long-acting injectable antipsychotics?.
Psychological Medicine,
Vol. 48,
Issue. 12,
p.
2098.
Stone, James M.
Roux, Simon
Taylor, David
and
Morrison, Paul D.
2018.
First-generation versus second-generation long-acting injectable antipsychotic drugs and time to relapse.
Therapeutic Advances in Psychopharmacology,
Vol. 8,
Issue. 12,
p.
333.
Deslandes, Paul Nicholas
Ward, Elan Haf
Norris, Kathryn
and
Sewell, Robert David
2018.
Effectiveness of paliperidone long-acting injection in clinical practice.
Therapeutic Advances in Psychopharmacology,
Vol. 8,
Issue. 5,
p.
139.
Taylor, David M.
Velaga, Sitaram
and
Werneke, Ursula
2018.
Reducing the stigma of long acting injectable antipsychotics – current concepts and future developments.
Nordic Journal of Psychiatry,
Vol. 72,
Issue. sup1,
p.
S36.
Emsley, Robin
Parellada, Eduard
Bioque, Miquel
Herrera, Berta
Hernando, Teresa
and
García-Dorado, Marta
2018.
Real-world data on paliperidone palmitate for the treatment of schizophrenia and other psychotic disorders.
International Clinical Psychopharmacology,
Vol. 33,
Issue. 1,
p.
15.
Mace, Shubhra
Dzahini, Olubanke
O’Hagan, Maria
and
Taylor, David
2018.
Haloperidol decanoate long-acting injection (HDLAI): Results of a 1-year mirror-image study.
Therapeutic Advances in Psychopharmacology,
Vol. 8,
Issue. 9,
p.
241.
Oh, So-Young
Jon, Duk-In
Hong, Hyun Ju
Hong, Narei
Yi, Jung-Seo
Roh, Daeyoung
and
Jung, Myung Hun
2019.
The Impact of Paliperidone Palmitate on Hospitalization in Patients with Schizophrenia: A Retrospective Mirror-image Study.
Clinical Psychopharmacology and Neuroscience,
Vol. 17,
Issue. 4,
p.
531.
Joo, Sung Woo
Shon, Seung-Hyun
Choi, GumJee
Koh, MinJung
Cho, Seung Woo
and
Lee, Jungsun
2019.
Continuation of schizophrenia treatment with three long-acting injectable antipsychotics in South Korea: A nationwide population-based study.
European Neuropsychopharmacology,
Vol. 29,
Issue. 9,
p.
1051.
Pilon, Dominic
Amos, Tony B.
Kamstra, Rhiannon
Manceur, Ameur M.
El Khoury, Antoine C.
and
Lefebvre, Patrick
2019.
Short-term rehospitalizations in young adults with schizophrenia treated with once-monthly paliperidone palmitate or oral atypical antipsychotics: a retrospective analysis.
Current Medical Research and Opinion,
Vol. 35,
Issue. 1,
p.
41.
Pappa, Sofia
Mason, Katy
and
Howard, Edward
2019.
Long-term effects of paliperidone palmitate on hospital stay and treatment continuation.
International Clinical Psychopharmacology,
Vol. 34,
Issue. 6,
p.
305.
Mace, Shubhra
Chak, Oscar
Punny, Sharanjeet
Sedough-Abbasian, Daniel
Vegad, Chirag
and
Taylor, David M.
2019.
Positive views on antipsychotic long-acting injections: results of a survey of community patients prescribed antipsychotics.
Therapeutic Advances in Psychopharmacology,
Vol. 9,
Issue. ,
p.
204512531986097.
Meca García, José Miguel
Soto Ontoso, Miguel
Gómez Padrón, Eliana
Sanchez-Waisen Hernández, María Rosa
and
Rojas Vallejo, Yaiza
2020.
Estudio observacional sobre los efectos del palmitato de paliperidona inyectable mensual sobre la hospitalización y asistencia urgente.
Psiquiatría Biológica,
Vol. 27,
Issue. 2,
p.
43.
Clark, Ivana
and
Taylor, David
2020.
Newer Formulations of Risperidone: Role in the Management of Psychotic Disorders.
CNS Drugs,
Vol. 34,
Issue. 8,
p.
841.
Bibekova, Zh. B.
Strel’cov, E. A.
and
Makarchuk, A. S.
2020.
APPLICATION OF ANTIPSYCHOTICS OF LONG-TERM ACTION IN SCHIZOPHRENIA.
Medical Herald of the South of Russia,
Vol. 11,
Issue. 1,
p.
6.
Wallman, Phoebe
Clark, Ivana
and
Taylor, David
2021.
Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice.
Journal of Psychopharmacology,
Vol. 35,
Issue. 9,
p.
1091.
Elbelushi, A.
Muravec, Z.
Masood, H.
and
Masood, B.
2021.
Alcohol-Induced Psychotic Disorder and Depressive Disorder: a Dual Diagnosis Case Series.
Neurology, Neuropsychiatry, Psychosomatics,
Vol. 13,
Issue. 5,
p.
130.
Laing, Emily
and
Taylor, David
2021.
Relapse and frequency of injection of monthly paliperidone palmitate—A retrospective case–control study.
European Psychiatry,
Vol. 64,
Issue. 1,
Comments
No Comments have been published for this article.